Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: Bob Rudd who wrote (1730)	2/19/2002 1:19:46 PM
From: Bob Rudd	Respond to of 10345

A number of Elan directors bought shares on Tuesday, at a price of €15.2. Mr Garo Armen bought 100,000 shares, Mr John Groom bought 60,000, Mr Brendan Boushel bought 35,000, Mr Dan Tully bought 25,000 and Mr Kieran McGowan bought 1,000. scripts.ireland.com

To: Bob Rudd who wrote (1730)	2/19/2002 2:05:06 PM
From: Robohogs	Read Replies (2) \| Respond to of 10345

The debt is already included in the line called cash/stock. Should be (net). I have been reading analyst reports and the one thing that is nerve-racking is that many have base profits under $1.00 (and even $0.50 and yes, even breakeven) even with $1.3 B in core product sales. If that were truly the case and ELN were adding new costs into such a sitation, I would be confused. I think pessimism is extreme. One analyst went so far as to say that if the SPE stockholdings were worthless ($0 for all stock in SPEs) then ELN would have a liquidity problem in a couple of years. Well, no shit. Jon